ARTICLE | Company News
Epigenomics' Epi proColon gets Priority Review
February 22, 2013 2:05 AM UTC
Epigenomics AG (Xetra:ECX) said FDA accepted and granted Priority Review to a PMA for its Epi proColon 2.0 test to detect colorectal cancer. Epigenomics said it expects a decision from FDA next half. ...